Features | Partner Sites | Information | LinkXpress
Sign In
Ampronix
Fluke Biomedical
GLOBETECH PUBLISHING

Medical Informatics Solutions Improve Patient Care

By HospiMedica International staff writers
Posted on 02 Apr 2014
Image: SurgeryPad (left) and MITK Pocket (right) (Photo courtesy of Mbits).
Image: SurgeryPad (left) and MITK Pocket (right) (Photo courtesy of Mbits).
Two innovative solutions provide data accessibility and imaging capabilities to ensure efficiency and the best possible treatment at the point-of-care (POC).

Developed by Mbits (Heidelberg, Germany), a spin-off company of the German Cancer Research Center (DKFZ; Heidelberg, Germany), the new solutions deliver medical imaging applications on mobile devices such as smartphones and tablets, the most rapidly developing technology platform in the history of mankind. The two solutions optimize multiple clinical POC uses, ranging from radiological workflows, intraoperative applications, and up to augmented reality.

MITK pocket, specifically designed for mobile devices, offers clinicians access to images while they are off-duty or off-ward, enabling direct inter-expert as well as physician-patient exchange, without being bound to stationary work places. Moreover, patients and clinicians alike may view and interact with images on their own mobile device using an intuitive user interface with sophisticated gesture input possibilities via an innovative motion sensor. Routinely used tools, such as annotations and measurements, are also available as individual level window settings and synchronized multiple window viewing.

An intelligent management capability downloads images in the background, which are then encrypted and stored locally on the device, removing the need of a permanent internet or Wi-Fi connection; Well-established authentication security measures protect image data and privacy. MITK pocket integrates with any picture archiving and communication system (PACS) via a minimal server application that is registered as a Digital Imaging and Communications in Medicine (DICOM) node.

The second innovation, SurgeryPad, is an augmented reality application for tablet computers that helps clinicians visualize individual, three-dimensional (3D) anatomy of patients which are virtually reconstructed from computed tomography (CT) or magnetic resonance imaging (MRI). The images are superimposed on the tablet display to provide an insight into the patient's individual anatomy prior to surgery. During surgery, the camera of the device captures the underlying scene and superimposes the corresponding organs on the display, accurately and in real-time.

Related Links:

Mbits
German Cancer Research Center



Bovie Medical
MinXray
Centurion Service

Channels

Critical Care

view channel

Busy Emergency Departments Offer Better Chance of Survival

A new analysis of hospitals in the United States finds that the busiest emergency departments (EDs) present the best chance of surviving, especially to patients whose condition is life-threatening. Researchers at the University of Michigan (U-M; Ann Arbor, USA) analyzed data from the Nationwide Inpatient Sample (NIS)... Read more

Surgical Techniques

view channel

Living Donor Liver Transplantation Relatively Safe

A new study shows that right liver lobe donor hepatectomy can be performed with minimal complication rates, increasing the potential donor pool dramatically. Researchers at Afyon Kocatepe University (AKU; Afyon, Turkey), Ege University (Izmir, Turkey), and International Kent Hospital (Izmir, Turkey) conducted a study... Read more

Women's Health

view channel
Image: A prototype contraceptive implant (Photo courtesy of MicroCHIPS).

Contraceptive Implant Hails New Era of Birth Control

A fingernail-sized implant holds enough 30-microgram daily doses of levonorgestrel to provide contraception for 16 years. Developed by MicroCHIPS (Lexington, MA, USA), a MIT (Cambridge, MA, USA) startup,... Read more

Business

view channel

Abbott Selling Developed Market Generics Portfolio

Abbott Laboratories (Abbot Park, IL, USA) has sold its developed market generic drugs business to Mylan (Canonsburg, PA, USA) in a deal worth USD 5.3 billion. The sale to Mylan will be in the form of an equity ownership of a newly formed entity, to be named Mylan NV, in which Abbott will have a stake of 21%.... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.